Delcath Systems, Inc. reported $95M of revenue over the trailing twelve months, +36% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $95M (to Q2 2026). Net income: $532K, trailing twelve months to Q2 2026. Free cash flow: $18M, trailing twelve months to Q2 2026. Operating margin: −2.7%, trailing twelve months to Q2 2026.

DCTHDelcath Systems, Inc.

Healthcare

$15.03+39% 1Y

$15.03

$8.1952 weeks$17.37

DCTH as reported

Delcath Systems, Inc. reported $95M of revenue over the trailing twelve months, +36% on the year before. 10 reported series are charted on this page, each one as filed.

$95M

Revenue, trailing twelve months · to Q2 2026 · +36% against the twelve months before

Net income: $532K
Net income · −76% year on year · trailing twelve months to Q2 2026
Free cash flow: $18M
Free cash flow · +353% year on year · trailing twelve months to Q2 2026
Operating margin: −2.7%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for DCTH, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$95M	+36%	Q2 2026
Net income	$532K	−76%	Q2 2026
EPS	$0.01	−86%	Q2 2026
Gross margin	87%	n/a	Q2 2026
Operating margin	−2.7%	n/a	Q2 2026
Net margin	−0.06%	n/a	Q2 2026
ROE	1.1%	n/a	Q2 2026
ROA	1.00%	n/a	Q2 2026
ROIC	356%	n/a	Q4 2024 · 6 quarters behind
Free cash flow	$18M	+353%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.